Shionogi and Aichi Prefecture Extends Cooperation on Preventing Drug Abuse

Since 2018, Shionogi and Aichi Prefecture in Japan have been working together to raise awareness for drug abuse prevention and encourage proper use of medicines. Now, the two are extending their collaboration for one more year. 

In 2021, Shionogi and Aichi Prefecture mainly focused on hosting activities such as web seminars. These online events, held in the shadow of the COVID-19 pandemic, sought to inform residents of Aichi Prefecture on how to avoid abusing drugs and use prescription narcotics with discretion. The seminars were sponsored by the Japanese Drug Organization of Appropriate Use and Research (J-DO), an Aichi-based NPO focused on promoting the proper use of drugs, and received support from the Aichi Pharmaceutical Association and the Aichi Society of Hospital Pharmacists. 

Drug Abuse in Japan

Japan is strict with drug use. Those who take drugs such as cannabis and methamphetamine are subjected to public shaming and stigma, and may also face jail time. Yet, an increasing number of people, especially youths, are taking these drugs, helped by ease of online access. 

Drug abuse covers more than stimulants. Patients may also overdose on prescription narcotics, which have traditionally played an important role in pain management, mainly for cancer pain. 

Home medical care is increasing in the rapidly aging Japanese society, complementing the progress of community-based comprehensive care. 

Shionogi has defined “Improve social productivity and extend healthy lifespans” as one of its key issues to address. Besides promoting proper use of prescription narcotics for cancer pain relief and palliative care, the company intends to implement more initiatives with Aichi Prefecture to prevent the misuse of medicines and help those suffering from chronic pain get relief without abusing prescription drugs. 

Related posts:

COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic Japan’s Shionogi to Provide 120 Million Doses of COVID-19 Vaccines Annually Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug AACR 2020: What Does Cancer Therapy Mean in the Time of COVID-19?

Author

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless